Added to YB: 2021-03-20
Pitch date: 2021-03-20
NVO:US [bullish]
Novo Nordisk A/S
+43.15%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products.
Market Cap
DKK 1.3T
Pitch Price
DKK 32.23
Price Target
N/A
Dividend
3.91%
EV/EBITDA
8.10
P/E
11.43
EV/Sales
4.31
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Novo Nordisk A/S Sponsored ADR Class B NVO:US
A summary for this pitch has not been created yet.
Read full article (0 min)